1.The influence of hypothyroid function in neonatal with hyperbilirubinemia by two kinds blue-light treatment way
Xianming GONG ; Yuhua LI ; Shiying YU
Chinese Journal of Primary Medicine and Pharmacy 2006;0(03):-
Objective To compare the influence of hypothyroid function in neonatal with hyperbilirubinemia by two kinds blue-light treatment way.Methods 36 cases were divided into the Bilibed infant blue light the bed treatment in 18 cases(group A) and the traditional warm box with the both blue light treatment in 18 cases(group B).The influence of hypothyroid function in neonatal with hyperbilirubinemia were observed after treatment and before treatment.Results The contents of bilirubin in two group after treatment were obviously lower than that before treatment(P0.05).Conclusion The therapeutic of Bilibed method can get the better therapeutic effect than the traditional warm box with the both blue light treatment for the neonatal with hyperbilirubinemia.The change of thyroid function was no influence.
2.One case of acute dimethyl formamide poisoning-induced subacute liver necrosis.
Mao-gong SHI ; Li LI ; Yu-qing SUI
Chinese Journal of Industrial Hygiene and Occupational Diseases 2004;22(3):234-234
Adult
;
Chemical and Drug Induced Liver Injury
;
Dimethylformamide
;
poisoning
;
Humans
;
Liver
;
pathology
;
Liver Diseases
;
blood
;
pathology
;
Male
;
Necrosis
;
Occupational Diseases
;
therapy
;
Poisoning
;
pathology
;
therapy
3.Neurotoxicity Mechanisms of Thrombin in Intracerebral Hemorrhage
Fa-Tao GONG ; Li-Ping YU ; Zhong-Gong WANG ; Fang-Min CHENG ;
International Journal of Cerebrovascular Diseases 2006;0(11):-
The thrombin is a neurotoxic agent,which plays an important role in the course of brain edema and brain injury following intracerebral hemorrhage.This article reviews the neurotoxicity mechanisms of thrombin in intracerebral hemorrhage.
4.Study the effect of argatroban injection on serum copeptin, NT-proBNP levels and clinical efficacy in patients with acute cerebral infarction
Shenghui CHEN ; Chunpeng LI ; Juan YU ; Jieqin GONG
Chinese Journal of Biochemical Pharmaceutics 2015;(3):150-152
Objective To explore the effect of argatroban injection on serum copeptin, NT-proBNP levels and clinical efficacy in patients with acute cerebral infarction.Methods 120 patients with acute cerebral infarction were selected neural department of internal medicine in our hospital .They were randomly divided into two groups, 60 patients in control group, treated with bed rest, oxygen, nutrition support treatment, giving control of blood pressure, blood glucose, lipid symptomatic disposal according to the disease, anti platelet aggregation, nourishing brain cells and other conventional treatment, 7 days for a course of treatment two course of treatment;the experimental group in the control group based on routine treatment, the first days with argatroban 60 mg,500 mL diluted with normal saline, 60 mg/d, 24 hcontinuous intravenous infusion for second days was given argatroban 20 mg, 200 mL diluted with normal saline,continuous intravenous pumping, total treatment 14 d.After the end of treatment, compared before and after treatment in patients with NIHSS (America National Institutes of Health Stroke), Barthel score (ADL) index score, serum copeptin, NT-proBNP levels and clinical efficacy.Results The two groups after treatment in patients with neurological functions were improved, compared with the control group, patients in the experimental group the NIHSS score was significantly lower , the difference was statistically significant (P<0.05).7 days after treatment, two groups of patients with self-care ability were improved, compared with the control group, patients in the experimental group significantly increased Barthel index score, the difference was statistically significant ( P <0.05 ); 14 days after treatment, compared with control group, patients in the experimental group significantly increased Barthel index score, the difference was statistically significant (P<0.05);14 days after treatment, compared with the same group 7days after treatment, patients in the experimental group significantly increased Barthel index score, the difference was statistically significant (P<0.05).After the treatment two groups of patients with serum copeptin, NT-proBNP levels were decreased, the experimental group patients serum copeptin, NT-proBNP levels were significantly lower than the control group, the difference was statistically significant (P <0.05). Efficiency of total the experiment group (96.7%) was significantly higher than the control group (80%), the difference was statistically significant (P<0.05).Conclusion Argatroban can significantly reduce the levels of serum copeptin, NT-proBNP levels in patients with, improve self-care ability recovery of nerve function and life, has a good clinical effect.
5.Construction of a micro-vascular network model in vitro by microfluidic technology for hemodynamic investigations
Yuan LI ; Beizhong LIU ; Fang GONG ; Chao YU ; Liyi HU
Military Medical Sciences 2014;(11):885-889
Objective The micro-vascular element plays a key role in the delivery of nutrients and the regulation of hemodynamic behavior, however, research is often hindered by ethical , economic and technological issues .Therefore, construction of a micro-vascular network in vitro will help to study the related pathological and physiological behavior in microvessels.Methods In this study, a micro-vascular element model with features of a micro-vascular network in vivo was designed based on the network structure of retinal arterioles .A micro-vascular network model in vitro, characterized by network asymmetry and the presence of both bifurcation-and side-branches , was developed by soft lithography technology . The developed microdevice allowed for the quantification of the cell -depletion layer ( CDL) thickness and hematocrit ( Ht) distribution within the microchannel networks .Results and Conclusion The study showed the potential of the developed in vitro model in revealing key hemodynamic features which have been detected for microvascular elements in vivo, including the relationships between CDL thickness , Ht and red blood cell distribution .The present study provides a new strategy and a technology for studying hemodynamics and microvascular system diseases in vitro.
6.The effect of cadmium on action potential of ventricular myocytes in guinea pig.
Shun-Kai GONG ; Guo-Bing YU ; Kun LI
Chinese Journal of Applied Physiology 2007;23(3):291-384
Action Potentials
;
drug effects
;
Animals
;
Cadmium
;
toxicity
;
Guinea Pigs
;
Male
;
Myocytes, Cardiac
;
drug effects
;
physiology
7.Neo-adjuvant chemotherapy of megestrol acetate in bereast cancer: short-term clinical study
Yu GONG ; Zhihua LI ; Ge CHEN ; Yali CAO
International Journal of Surgery 2010;37(1):17-20
Objective To observe the role of short-term use of megestrol acetate in reducing the toxicity of chemotherapy in breast cancer and in improving the quality of life of patients, as well as its impact on neo-adjuvant chemotherapy effects. Methods The effection of adjuvant chemotherapy, toxicity, and the quality of life of 158 patients with breast cancer were investigated by a retrospective control study. The data were statistically analysized by X~2 test. Results There was no significant difference of neo-adjuvant chemotherapy effects between Megestrol acetate + CEF chemotherapy group and vitamin C + CEF chemotherapy group (Megestrol acetate + CEF chemotherapy group was 74. 84%, vitamin C + CEF chemotherapy group was 76.15) ; Megestrol acetate + CEF chemotherapy group had more modest bone marrow suppression and gas-trointestinal reactions and better food intake, weight, KPS score than vitamin C + CEF Chemotherapy group, all the differences being statistically significant (P < 0.05). Conclusion Short-term use of megestrol ace-tate can reduce the adverse effects derived from chemotherapy of breast cancer and improve the quality of life of patients with breast cancer and had no effects on the efficacy of the neo-adjuvant chemotherapy.
9.Studies on mechanism of polycystic ovary syndrome and the diagnosis and treatment princial for adolescents.
Chun-xiu GONG ; Yu-chuan LI ; Di WU
Chinese Journal of Pediatrics 2012;50(6):425-428
Adolescent
;
Amenorrhea
;
diagnosis
;
etiology
;
Androgen Antagonists
;
pharmacology
;
Androgens
;
blood
;
Contraceptive Agents
;
pharmacology
;
Female
;
Humans
;
Hyperandrogenism
;
complications
;
Hypoglycemic Agents
;
therapeutic use
;
Insulin Resistance
;
Luteinizing Hormone
;
blood
;
Menstruation Disturbances
;
diagnosis
;
etiology
;
Obesity
;
complications
;
Ovary
;
diagnostic imaging
;
pathology
;
Polycystic Ovary Syndrome
;
diagnosis
;
etiology
;
therapy
;
Ultrasonography
;
Young Adult